Another interesting announcement from our "competitor" (LIS Technologies) at

https://email.telstra.com/app/mail/inbox/eyJNZXNzYWdlIjoiZXlKTllXbHNZbTk0SWpvaVpYbEtUMWxYTVd4SmFtOXBVMVUxUTFReFoybE1RMHBGV2xkNGNHSlhiREJhV0VscFQybEpka2xwZDJsV1ZXeEZWbWxKTmsxVVRYbE5SR3N5VDFSVmQwMXVNRDBpTENKVlNVUWlPakUxTVRneE5Dd2lUVzlrVTJWeElqb3dmUT09IiwiWEdNVEhSSUQiOjB9

What I found particularly interesting was paragraph I have emboldened and underlined. In this you can see that LIST concede that they have a less efficient laser and irradiation technology (i.e "CRISLA features a streamlined Separator design due to lower beam caustics and lower absorption at 5.3µm, compared to the traditional pulsed 10.6/16µm CO2 lasers") and are selling "a streamlined separator design" (no doubt the Eerkins developed condensation suppression technology). In this technology the property the "excited" ²³⁵UF₆/G is slightly less keen to condense to a liquid than the "unexcited" ²³⁸UF₆/G so that the tails product (the ²³⁸UF₆) condenses first and the "product" (²³⁵UF₆/G) passes through as a gas (or condenses later).

LIS Technologies Inc. Strengthens its Executive Advisory Board with the Addition of Dr. Junaid Razvi as its Senior Advisor in Nuclear Energy

LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that Junaid Razvi Ph.D., has been appointed to the Company’s Executive Advisory Board as a Senior Advisor in Nuclear Energy. Dr. Razvi is a seasoned nuclear technology professional with nearly four decades of experience across scientific, policy, regulatory, and economic domains. His expertise includes the design, licensing, construction, operation, and utilization of nuclear reactors and related systems.

Figure 1 - LIS Technologies Inc. Appoints Junaid Razvi, Ph.D., to its Executive Advisory Board as its Senior Advisor in Nuclear Energy

During his tenure at General Atomics (GA), Dr. Razvi played a pivotal role in advanced nuclear fission programs. He spearheaded initiatives to develop intellectual property and establish domestic production of critical medical radioisotopes, earning recognition from the U.S. Congress and the Department of Energy. Additionally, Dr. Razvi directed GA’s global activities for its TRIGA® reactor facilities, overseeing installations in 23 nations, and managed GA’s nuclear facilities, including research reactor operations and nuclear fuel manufacturing. Dr. Razvi holds a Ph.D. in Nuclear Engineering from Kansas State University, a Master’s in Nuclear Engineering from the University of Washington, and a bachelor’s degree in liberal arts with a focus on Physics and Mathematics from Wabash College, Indiana. “I'm delighted to be a part of the drive to establish robust domestic uranium enrichment capabilities within the United States,” said Junaid Razvi Ph.D., Senior Advisor in Nuclear Energy of LIS Technologies Inc. “The nuclear energy industry has seen tremendous support both domestically and internationally in recent years, and we are perfectly positioned to make the most of the growing momentum.” Dr. Razvi also managed a U.S.-Russia collaboration to develop advanced modular GEN-IV gas-cooled reactor technology, ensuring compliance with bilateral treaties for plutonium disposal from dismantled nuclear weapons. Furthermore, Dr. Razvi contributed to developing solutions for the safe transport of used nuclear fuel. LIS Technologies’ demonstrated US-origin Condensation Repression Isotope Selective Laser Activation (CRISLA) technology offers a practical approach to enhancing domestic uranium enrichment capabilities. It differs from traditional methods by utilizing advanced laser enrichment techniques, which provide unmatched scalability and efficiency. Designed for both Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU), CRISLA features a streamlined Separator design due to lower beam caustics and lower absorption at 5.3µm, compared to the traditional pulsed 10.6/16µm CO2 lasers. These technical improvements contribute to more efficient operations and cost management, addressing some of the limitations found in prior art laser enrichment technologies and supporting the sustainable production of enriched uranium domestically. “It is a pleasure to welcome Dr. Razvi to the LIS Technologies team,” said Christo Liebenberg, Chief Executive Officer of LIS Technologies Inc. “Dr. Razvi brings extensive expertise that will enable him to integrate seamlessly into the Company’s operations to help focus on design, engineering and construction activities. His deep understanding of regulatory pathways and well-established industry relationships will be invaluable as we pursue our expansion strategy.”